DEAR — Duearity AB Share News
0.000.00%
Last trade - 00:00- SEK8.52m
- SEK12.74m
- SEK1.65m
Brief: Duearity Signs Distributor Agreement In UK
Brief: Duearity's Tinearity G1 Gets Market Approval In USA
Brief: Positive Results From Duearity's User Study On People With Tinnitus
Brief: Duearity Enters Agreement With Distributor In Portugal
Brief: Duearity's Tinearity G1 Gets Market Approval In UK
Brief: Duearity Establishes Unit In The U.S.
Brief: Duearity Granted Export Loan Of SEK 3.8 Mln
Brief: Duearity Q4 Pretax Loss Narrows To SEK 4.2 Mln
Brief: Duearity Carries Out Directed Share Issue Of SEK 8 Mln
Brief: Duearity To Launch, Distribute Tinnitus Product After CE Approval
Brief: Duearity Gets CE Approval For Tinearity G1
Brief: Duearity Submits FDA 510(K) Clearance Application For Tinearity G1
Brief: Duearity Enters Reseller Agreement With Transistor Sweden
Brief: Duearity Signs Letter Of Intent With U.S. Company
Brief: Duearity Q3 Pretax Loss Widens To SEK 4.0 Million
Brief: Duearity To Apply For Approval Of Tinnitus Product In U.S.
Brief: Duearity: Swedish Patent And Registration Office Intends To Approve Co's Patent Application
Brief: Duearity: New Chairman Of Board
Brief: Duearity Q2 Operating Loss Widens To SEk 5.4 Mln